Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3961)
All Articles published online
|
Apr 14, 2012 (publication date) through May 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kalambokis GN, Mouzaki A, Rodi M, Tsianos EV. Rifaximin for the prevention of spontaneous bacterial peritonitis. World J Gastroenterol 2012; 18(14): 1700-1702 [PMID: 22529702 DOI: 10.3748/wjg.v18.i14.1700] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i14/1700.htm |
| Number | Citing Articles |
| 1 |
Federica Di Vincenzo, Alberto Nicoletti, Marcantonio Negri, Federica Vitale, Lorenzo Zileri Dal Verme, Antonio Gasbarrini, Francesca Romana Ponziani, Lucia Cerrito. Gut Microbiota and Antibiotic Treatments for the Main Non-Oncologic Hepato-Biliary-Pancreatic Disorders. Antibiotics 2023; 12(6): 1068 doi: 10.3390/antibiotics12061068
|
| 2 |
Peter Huebener, Robert F. Schwabe. Regulation of wound healing and organ fibrosis by toll-like receptors. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2013; 1832(7): 1005 doi: 10.1016/j.bbadis.2012.11.017
|
| 3 |
R. Ennaifer, N. Elleuch, M. Cheikh, H. Romdhane, H. Ben Nejma, N. Bel Hadj. La rifaximine : une nouvelle alternative dans la prévention des infections bactériennes chez le cirrhotique ?. Journal Africain d'Hépato-Gastroentérologie 2015; 9(3): 122 doi: 10.1007/s12157-015-0606-8
|
| 4 |
Hiroshi Fukui. Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia. World Journal of Hepatology 2015; 7(3): 425-442 doi: 10.4254/wjh.v7.i3.425
|
| 5 |
Ahmed A. Ghafar, Salah Rozaik, Ahmed Akef. Rifaximin plus norfloxacin versus norfloxacin alone in primary prophylaxis of spontaneous bacterial peritonitis in patients with variceal bleeding. The Egyptian Journal of Internal Medicine 2019; 31(3): 281 doi: 10.4103/ejim.ejim_6_19
|
| 6 |
Asem Elfert, Lobna Abo Ali, Samah Soliman, Shimaa Ibrahim, Sherief Abd-Elsalam. Randomized-controlled trial of rifaximin versus norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis. European Journal of Gastroenterology & Hepatology 2016; 28(12): 1450 doi: 10.1097/MEG.0000000000000724
|
| 7 |
Katerina Klímová, Camilo Padilla, Juan Carlos Ávila, Gerardo Clemente, Alejandra Ochoa. Epidemiología de las infecciones bacterianas en pacientes con cirrosis hepática. Expericencia de un centro terciario español. Biomédica 2015; 36(1) doi: 10.7705/biomedica.v36i1.2600
|
| 8 |
Nina Kimer, Mads Meldgaard, Ole Hamberg, Thit Mynster Kronborg, Allan M. Lund, Holger Jon Møller, Flemming Bendtsen, Henriette Ytting, Wan-Long Chuang. The impact of rifaximin on inflammation and metabolism in alcoholic hepatitis: A randomized clinical trial. PLOS ONE 2022; 17(3): e0264278 doi: 10.1371/journal.pone.0264278
|
| 9 |
M. Assem, M. Elsabaawy, M. Abdelrashed, S. Elemam, S. Khodeer, W. Hamed, A. Abdelaziz, G. El-Azab. Efficacy and safety of alternating norfloxacin and rifaximin as primary prophylaxis for spontaneous bacterial peritonitis in cirrhotic ascites: a prospective randomized open-label comparative multicenter study. Hepatology International 2016; 10(2): 377 doi: 10.1007/s12072-015-9688-z
|
| 10 |
Harry D Zacharias, Fady Kamel, Jaclyn Tan, Nina Kimer, Lise Lotte Gluud, Marsha Y Morgan. Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosis. Cochrane Database of Systematic Reviews 2023; 2023(7) doi: 10.1002/14651858.CD011585.pub2
|
| 11 |
Angelo Alves de Mattos, Ane Micheli Costabeber, Livia Caprara Lionço, Cristiane Valle Tovo. Multi-resistant bacteria in spontaneous bacterial peritonitis: A new step in management?. World Journal of Gastroenterology 2014; 20(39): 14079-14086 doi: 10.3748/wjg.v20.i39.14079
|
| 12 |
Paola Leone, Gergana Mincheva, Tiziano Balzano, Michele Malaguarnera, Vicente Felipo, Marta Llansola. Rifaximin Improves Spatial Learning and Memory Impairment in Rats with Liver Damage-Associated Neuroinflammation. Biomedicines 2022; 10(6): 1263 doi: 10.3390/biomedicines10061263
|
| 13 |
Fred F. Poordad. Presentation and complications associated with cirrhosis of the liver. Current Medical Research and Opinion 2015; 31(5): 925 doi: 10.1185/03007995.2015.1021905
|
| 14 |
Edna Strauss. The impact of bacterial infections on survival of patients with decompensated cirrhosis. Annals of Hepatology 2014; 13(1): 7 doi: 10.1016/S1665-2681(19)30899-3
|
| 15 |
Sehrish Jahan Asif, Murataza Gondal, Shahida Parveen, Sumera Mushtaq, Shumaila Awan, Tassawar Hussain. The pattern of microbial flora in Spontaneous bacterial peritonitis in Cirrhotic patients. Journal of Rawalpindi Medical College 2020; : 62 doi: 10.37939/jrmc/vol24.iss1.13
|
| 16 |
|
| 17 |
Amr Menshawy, Omar Mattar, Kirolos Barssoum, Ammar M. AboEl-Naga, Haitham Mohamed Salim, Ahmed Mesbah Fahmy Mohamed, Ahmed Elgebaly, Sherief Abd-Elsalam. Safety and Efficacy of Rifaximin in Prophylaxis of Spontaneous Bacterial Peritonitis: A Systematic Review and Meta-analysis. Current Drug Targets 2019; 20(4): 380 doi: 10.2174/1389450119666180924145156
|